ECO Animal Health Group plc
(''ECO" or the "Group") (AIM: EAH)
Investor Presentation covering Interim Results
ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, is pleased to announce that David Hallas, CEO, and Christopher Wilks, CFO, will be conducting a live presentation covering the Group's interim results for the period ended 30 September 2023.
The online presentation will take place on Wednesday 29 November at 3.00pm UK time. This event is open to all existing and potential shareholders and registration is free. Questions can be submitted during the presentation and will be addressed at the end of it.
To register for the event, please click here
A video recording of the presentation will be available shortly afterwards here
Contacts:
| ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO)
|
|
| IFC Advisory Graham Herring Zach Cohen
| 020 3934 6630
|
| Equity Development Hannah Crowe Matt Evans | 020 7065 2692 |
About ECO Animal Health
ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
